Leerink Believes Keytruda Can Carry Merck Stock Higher

Merck stock has found chart support at a 20% pullback from its annual high

Mar 12, 2018 at 10:03 AM
facebook X logo linkedin


Dow stock Merck & Co., Inc. (NYSE:MRK) has fallen under pressure in recent months. MRK shares suffered a huge bear gap back in October after the company pulled its European marketing application for Keytruda, and last month they were hit when rival Bristol-Myers Squibb (BMY) announced a positive trial update for Opdivo. However, Merck stock is bouncing today following a bullish brokerage note.

Specifically, Leerink upgraded the blue chip to "outperform" from "market perform," while maintaining a price target of $66. The covering analyst expects the company to upwardly revise its estimates for Keytruda over the next year or so, adding the drug will hold off Bristol-Myer's Opdivo to maintain its position as market leader for non-small cell lung cancers. MRK stock is up 1.7% at $56.02 in response.

The $56 level -- the site of the year-to-date breakeven mark -- has been troublesome for the equity in recent weeks, but the $53-$54 region has been supportive since October. In fact, the $53 mark is roughly a 20% decline from the shares' 52-week high of $66.41, suggesting it could continue to represent a layer of technical support going forward.

Options traders have been betting bullishly in recent weeks, too. For starters, call buying has more than tripled put buying during the past 10 weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). And in the last two weeks in particular, the June 60 call has seen the largest increase in open interest by a long shot.

The majority of covering analysts agree with Leerink's bullish assessment, too, with seven of 13 handing out "strong buy" recommendations. Plus, the average 12-month price target remains up at $66.24 -- a more than 18% premium to current levels.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI